Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Reaches New 12-Month High – Here’s What Happened

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY)’s share price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $10.75 and last traded at $10.57, with a volume of 78810 shares traded. The stock had previously closed at $10.3950.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 0.5%

The business has a fifty day simple moving average of $9.16 and a 200 day simple moving average of $8.79. The stock has a market cap of $18.57 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.05 and a beta of 0.19. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.74 and a current ratio of 6.44.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its quarterly earnings results on Friday, January 30th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.09. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.88% and a net margin of 41.82%.The company had revenue of $966.53 million during the quarter, compared to the consensus estimate of $848.42 million. As a group, equities analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.